Compass Therapeutics, Inc. (CMPX)
NASDAQ
Market Cap
$145.84M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
540 of 809
Rank in Industry
295 of 445
Largest Insider Buys in Sector
CMPX Stock Price History Chart
CMPX Stock Performance
About Compass Therapeutics, Inc.
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company's product candidates in the clinical stage of development include CTX-009, an investigational bispecific antibody that blocks Delta-like ligand 4/Notch and vascular endothelial growth factor A signaling pathways, which are critical to angiogenesis and tumor vascularization; and CTX-471, an IgG4 monoclonal antibody that is an agonist of CD137. Its product candidates also comprise CTX-8371, a bispecific inhibitor that targets PD-1 and PD-L1. The company was founded in 2014 and is headquartered in Boston, Massachusetts.
Insider Activity of Compass Therapeutics, Inc.
Over the last 12 months, insiders at Compass Therapeutics, Inc. have bought $0 and sold $0 worth of Compass Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Compass Therapeutics, Inc. have bought $19.83M and sold $103,708 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 10,000 shares for transaction amount of $33,700 was made by Schuetz Thomas J. (CHIEF EXECUTIVE OFFICER) on 2023‑03‑10.
List of Insider Buy and Sell Transactions, Compass Therapeutics, Inc.
| 2023-03-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 10,000 0.008% | $3.37 | $33,700 | -31.63% | ||
| 2023-02-27 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.016% | $3.98 | $79,600 | -39.44% | ||
| 2023-02-15 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.0153% | $3.86 | $77,200 | -38.82% | ||
| 2023-01-31 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.016% | $4.05 | $81,000 | -35.38% | ||
| 2023-01-24 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.0158% | $4.19 | $83,800 | -37.05% | ||
| 2022-11-25 | Sale | Bisker-Leib Vered | Chief Operating Officer | 2 <0.0001% | $4.36 | $9 | -28.83% | |
| 2022-11-23 | Sale | Bisker-Leib Vered | Chief Operating Officer | 9,569 0.0088% | $4.30 | $41,147 | -29.89% | |
| 2022-11-22 | Sale | Bisker-Leib Vered | Chief Operating Officer | 14,929 0.0139% | $4.19 | $62,553 | -27.27% | |
| 2022-11-08 | ORBIMED ADVISORS LLC | director | 402,000 0.2887% | $3.21 | $1.29M | -25.18% | ||
| 2022-11-08 | GORDON CARL L | director | 402,000 0.2887% | $3.21 | $1.29M | -25.18% | ||
| 2022-09-07 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 15,000 0.0148% | $3.03 | $45,450 | +4.92% | ||
| 2022-09-01 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 15,000 0.0145% | $2.83 | $42,450 | +10.34% | ||
| 2022-08-17 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 15,000 0.0151% | $3.05 | $45,750 | +6.67% | ||
| 2022-08-10 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 15,000 0.0146% | $2.64 | $39,600 | +19.40% | ||
| 2022-08-01 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 15,000 0.0145% | $2.58 | $38,700 | +21.21% | ||
| 2022-06-21 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.019% | $2.80 | $56,000 | +9.25% | ||
| 2022-06-16 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.0188% | $2.34 | $46,800 | +28.74% | ||
| 2022-06-13 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 30,000 0.0339% | $2.29 | $68,700 | +57.71% | ||
| 2022-06-06 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 30,000 0.0304% | $2.83 | $84,900 | +14.08% | ||
| 2022-06-01 | Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 20,000 0.0206% | $3.03 | $60,600 | +8.22% |
Insider Historical Profitability
12.91%
| GORDON CARL L | director | 15219994 11.9386% | $1.06 | 5 | 0 | +26.53% |
| ORBIMED ADVISORS LLC | director | 15219994 11.9386% | $1.06 | 3 | 0 | <0.0001% |
| OrbiMed Genesis GP LLC | 14690178 11.523% | $1.06 | 2 | 0 | +76.65% | |
| Schuetz Thomas J. | CHIEF EXECUTIVE OFFICER | 6021873 4.7236% | $1.06 | 20 | 0 | +7.18% |
| Sunderland Julie | director | 2502025 1.9626% | $1.06 | 1 | 0 | |
| Ferneau Philip | director | 2348976 1.8425% | $1.06 | 1 | 0 | |
| Bisker-Leib Vered | Chief Operating Officer | 1060414 0.8318% | $1.06 | 0 | 3 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| OrbiMed | $44.28M | 16.25 | 22.36M | 0% | +$0 | 0.9 | |
| Adage Capital Partners Gp L L C | $22.04M | 8.09 | 11.13M | +12.65% | +$2.48M | 0.04 | |
| Janus Henderson | $12.82M | 4.72 | 6.49M | -0.83% | -$107,303.75 | 0.01 | |
| Blackstone | $12.26M | 4.5 | 6.19M | 0% | +$0 | 0.05 | |
| BlackRock | $11.94M | 4.38 | 6.03M | -3.05% | -$375,889.15 | <0.0001 | |
| Cormorant Asset Management Lp | $11.01M | 4.04 | 5.56M | New | +$11.01M | 0.52 | |
| ROCK SPRINGS CAPITAL MANAGEMENT, LP | $10.92M | 4.01 | 5.51M | 0% | +$0 | 0.28 | |
| Fidelity Investments | $8.94M | 3.28 | 4.52M | -0.8% | -$72,010.63 | <0.01 | |
| The Vanguard Group | $8.22M | 3.02 | 4.15M | +1.74% | +$140,595.84 | <0.0001 | |
| Vivo Capital | $7.04M | 2.59 | 3.56M | 0% | +$0 | 0.62 | |
| Opaleye Management Inc | $6.28M | 2.3 | 3.17M | New | +$6.28M | 0.99 | |
| Blue Owl Capital Holdings Lp | $5.6M | 2.06 | 2.83M | 0% | +$0 | 1.06 | |
| Geode Capital Management | $4.11M | 1.51 | 2.08M | +4.18% | +$164,968.24 | <0.0001 | |
| Bioimpact Capital Llc | $3.9M | 1.43 | 1.97M | New | +$3.9M | 0.63 | |
| State Street | $3.62M | 1.33 | 1.83M | +5.79% | +$197,748.52 | <0.0001 | |
| Baker Bros Advisors LP | $3.08M | 1.13 | 1.56M | 0% | +$0 | 0.04 | |
| Northern Trust | $1.52M | 0.56 | 766,911 | +0.94% | +$14,212.44 | <0.0001 | |
| Monashee Investment Management LLC | $990,000.00 | 0.36 | 500,000 | 0% | +$0 | 0.09 | |
| Wellington Management Company | $634,829.00 | 0.23 | 320,621 | New | +$634,829.00 | <0.0001 | |
| Cm Management Llc | $613,800.00 | 0.23 | 310,000 | +148% | +$366,300.00 | 0.03 | |
| Nuveen | $602,918.00 | 0.22 | 304,504 | 0% | +$0 | <0.0001 | |
| BNY Mellon | $499,959.00 | 0.18 | 252,505 | -6.88% | -$36,944.75 | <0.0001 | |
| Connor Clark & Lunn Investment Management Ltd | $476,784.00 | 0.18 | 240,800 | +13.07% | +$55,113.30 | <0.01 | |
| Charles Schwab | $475,586.00 | 0.18 | 240,195 | -2.37% | -$11,517.66 | <0.0001 | |
| Pennant Capital Management Llc | $394,020.00 | 0.15 | 199,000 | 0% | +$0 | 0.06 | |
| Millennium Management LLC | $383,659.00 | 0.14 | 193,767 | -60.78% | -$594,644.03 | <0.0001 | |
| Morgan Stanley | $325,176.00 | 0.12 | 164,231 | -27.97% | -$126,242.28 | <0.0001 | |
| Exchange Traded Concepts, LLC | $290,811.00 | 0.11 | 146,874 | +123.15% | +$160,489.17 | 0.01 | |
| Citadel Advisors LLC | $285,486.00 | 0.11 | 144,185 | -13.21% | -$43,464.91 | <0.0001 | |
| Two Sigma | $280,451.00 | 0.1 | 141,642 | -26.5% | -$101,094.78 | <0.0001 | |
| Pale Fire Capital Se | $249,417.00 | 0.09 | 125,968 | -30.43% | -$109,072.42 | <0.01 | |
| Goldman Sachs | $242,970.00 | 0.09 | 122,712 | -40.6% | -$166,092.46 | <0.0001 | |
| RhumbLine Advisers | $236,551.00 | 0.09 | 119,474 | +2.52% | +$5,824.98 | <0.0001 | |
| DAFNA Capital Management, LLC | $231,426.00 | 0.09 | 116,882 | 0% | +$0 | 0.05 | |
| UBS | $218,218.00 | 0.08 | 110,211 | +7.47% | +$15,172.75 | <0.0001 | |
| Barclays | $150,000.00 | 0.06 | 75,913 | -39.51% | -$97,953.58 | <0.0001 | |
| Renaissance Technologies | $139,000.00 | 0.05 | 70,400 | -60.18% | -$210,077.57 | <0.0001 | |
| Two Sigma Advisers LP | $117,414.00 | 0.04 | 59,300 | -16.24% | -$22,770.00 | <0.0001 | |
| Squarepoint Ops LLC | $100,608.00 | 0.04 | 50,812 | -42.73% | -$75,058.02 | <0.0001 | |
| MetLife Investment Management | $100,049.00 | 0.04 | 50,530 | +1.16% | +$1,142.45 | <0.01 | |
| National Asset Management Inc | $98,500.00 | 0.04 | 50,000 | 0% | +$0 | <0.01 | |
| American International Group | $89,049.00 | 0.03 | 44,974 | -0.85% | -$764.28 | <0.0001 | |
| Bank of America | $89,920.00 | 0.03 | 45,414 | -50.37% | -$91,242.64 | <0.0001 | |
| Caxton Corp | $86,062.00 | 0.03 | 43,465 | 0% | +$0 | 0.5 | |
| Deutsche Bank | $84,522.00 | 0.03 | 42,688 | -4.32% | -$3,813.47 | <0.0001 | |
| Invesco | $82,690.00 | 0.03 | 41,763 | -3.3% | -$2,825.43 | <0.0001 | |
| Simplicity Wealth Llc | $79,681.00 | 0.03 | 40,243 | New | +$79,681.00 | <0.01 | |
| Bleakley Financial Group Llc | $79,681.00 | 0.03 | 40,243 | New | +$79,681.00 | <0.01 | |
| JPMorgan Chase | $75,939.00 | 0.03 | 38,353 | -38.47% | -$47,478.46 | <0.0001 | |
| The Manufacturers Life Insurance Company | $76,004.00 | 0.03 | 38,386 | +2.31% | +$1,714.67 | <0.0001 |